Biological differences on onset among type 1A diabetics in relation to HLA-DQ genetic markers;Diferencias biológicas en la presentación de la diabetes 1A, en relación con los marcadores genéticos HLA-DQ

Medicina Clinica

Volumn 120, Issue 1, 2003, Pages 6-9

  Giralt Muiña, Patricio ^a   Urra Ardanaz, José Miguel ^a   Sanabria Pérez, Concepción ^a   Giralt Muiña, Juan ^b   Pérez Rodríguez, María José ^a   Benito López, Pedro ^c  

^a Hospital Alarcos   (Spain)

^b UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

DQ haplotypes; Genetic study; Type 1 diabetes mellitus

Indexed keywords

C PEPTIDE; HLA DQ ANTIGEN;

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; CLINICAL FEATURE; CLINICAL STUDY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENDER; GENETIC ANALYSIS; HAPLOTYPE; HETEROZYGOSITY; HUMAN; HYPOTHESIS; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MOLECULAR BIOLOGY; ONSET AGE; PANCREAS FUNCTION; PROBABILITY; RISK ASSESSMENT; SEROLOGY;

EID: 0037452261     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(03)73587-8     Document Type: Article

References (30)

1. Lhor M, Kloppel G. Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-independent) diabetes mellitus and microangiopathy. Diabetologia 1987; 30:757-62.
2. Pipeleers D, Ling Z. Pancreatic beta cells in insulin-dependent, diabetes mellitus. Diabetes Metab Rev 1992;8:209-27.
3. Gjessing HJ, Matzen LE, Faber OK, Froland A. Fasting plasma C-peptide, glucagon stimulated C-peptide and urinary C-peptide in relation to clinical type of diabetes. Diabetologia 1989;32: 305-11.
4. Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EA, et al. 1990 Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990;335:147-9.
5. Atkinson MA, MacLaren NK, Riley WJ, Winter WE, Fisk DD, Spillar RP. Are insulin autoantibodies markers for insulin-dependent diabetes mellitus? Diabetes 1986;35:894-8.
6. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, et al. Identification of the 64K autoantigen in insulin-dependent diabetes as GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990;347:151-6.
7. Barrios Castellano R, Diabetes mellitus en la infancia y la adolescencia. Madrid: Diaz de Santos, 1997.
8. Biamesa J, Rojas I, Fernández-Castaner M, Núnez V, Gómez M, Ricart W. Estudio de las mutaciones A32436, C3256T y deleción mitocondriales en 41 pacientes diabéticos. Med Clin (Barc) 2001;116:292-3.
9. Maclaren N. Riley W, Skordis N, Atkinson M, Spillar R, Silverstein J. Inherited susceptibility to insulin-dependent diabetes is associated with HLA-DR1, while DR5 is prospective. Autoinmun 1998;1:197-205.
10. Thorsby E, Gjerten H, Kea L, Ronningen KS. Insulin dependent diabetes mellitus susceptibility or protection may be determined by certain HLA-DQ molecules. Bailleres Clin Endocrinol Metab 1991;5:361-73.
11. Vicario JL, Martinez Laso J, Corell A, Martin-Villa JM, Morales P, Lledó G, et al. Comparison betwen HLA-DRB and DQ DNA secuences and classic serological markers as type 1 diabetes mellitus predictive risk markers in the Spanish population. Diabetologia 1992;35:475-81.
12. Khalil I, D'Aurio L, Gobet M, Morin L, Lepage V, Deschamp I, et al. A combination of HLA DQB Asp 57 negative and insulin-dependent diabetes mellitus. J Clin Invest 1990;855:1315-9.
13. Komulainen J, Kulmala P, Savola K, Lounamea R, Ilonen J, Reijonen H, et al. Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Diabetes Care 1999;22:1950-5.
14. Giralt Muiña P, Santillana Ferrer L, Madrigal Barchino D, Merlo Garrido A, Toledo de la Torre B, Anaya Barea F. Incidencia en menores de 16 años y prevalencia de la diabetes mellitus tipo 1 A en la provincia de Ciudad Real. An Esp Pediatr 2001;55:213-8.
15. The Expert Committee on the Diagnosis and classification of diabetes mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1977; 20:1183-97.
16. Giralt Muiña P, Sánchez del Pozo J, Anaya Barea F, Garcia Silva MT, Lledó Varela G, Rosa García A. Diabetes neonatal permanente asociada a hipotiroidismo, sordera y rasgos dismórficos. An Esp Pediatr 2001;54:520-3.
17. Type 2 diabetes in children and adolescent. American Diabetes Association. Diabetes care 2000; 23:381-9.
18. Sánchez Carrión JJ. Manual de análisis de datos. Madrid: Alianza Universidad Textos, 1995.
19. Calvo B, Bilbao JR, Castaño L, Contribución de los microsatélites D6S1014 y D6S273, en la región HLA, al riesgo de diabetes tipo 1. An Esp Pediatr 2000;52:2.
20. Bilbao JR, Calvo B, Urrutia I, Castaño I. Bases genéticas de la diabetes tipo 1. Endocrinoloía 1996;43:312-20.
21. Wallensteen M, Dahlquist G, Persson B, Landin-Olsson M, Lemmark A, Sundkvist G. Factors influencing the magnitude, duration, and rate of fall of Beta-cell function in type 1 (insulin-dependent) diabetes children followed for two years from their clinical diagnosis. Diabetologia 1998;31:664-9.
22. Knip M, Ilonen J, Mustonen A, Akerblom HK. Evidence of an accelerated beta-cell destruction in HLA Dw3/Dw4 heterozygous. Diabetologia 1986;19:347-51.
23. Vandewalle CL, Decraene T, Schuit FC, De Leeuw IH, Pipeleers DG, Gorus FK. Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA-DQA* 0301-DQB*0302 haplotype at clinical onset of type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years. Diabetologia 1993;36:1155-62.
24. Caillat-Zucman S, Garchon HJ, Timsit J, Assan R, Boitard C, Djilali-Saiah I, et al. Age-dependent HLA genetic heterogeneity of type1 insulin-dependent diabetes mellitus. J Clin Invest 1992; 90:2242-50.
25. Nepom GT, William WK. Molecular basis for HLA-DQ association with IDDM. Diabetes 1998; 47:1177-84.
26. Keller RJ, Eisenbarth GS, Jackson RA. Insulin prophylaxis in individuals at high risk of type 1 diabetes. Lancet 1993;341:927-8.
27. Shah SC, Malone JI, Simpson NE. A randomized trial of intensive insulin therapy in newly diagnosed type 1 insulin-dependent diabetes mellitus. N Engl J Med 1989;320:550-4.
28. Rodríguez-Villar C, Conget I, Estmatges E, Levy I, Calvet J, Figuerola D, et al. Presencia de marcadores predictivos del estado de prediabetes mellitus tipo 1 en familiares de pacientes con diabetes mellitus tipo 1. Med Clin (Barc) 1996; 107:371-4.
29. Plensa I, Pavía C, Ercilla MG, Gallart M, Valls C, Pérez I. Estudio familiar para el diagnóstico precoz de la diabetes mellitus insulindependiente. Med Clin (Barc) 1992;99:132-6.
30. Oyarzabal M, Chueca M, López MJ, Luzuriaga C, Rica I, Rodriguez M, et al. Características del debut y evolución en el niño menor de 5 años con Diabetes tipo 1: Estudio colaborativo. Actas de VI Jornada de Diabetes del Niño y Adolescente de la SEEP 2001;82.